Clorox Co (NYSE:CLX) has been given a consensus rating of “Hold” by the fourteen brokerages that are covering the firm, MarketBeat.com reports. Four investment analysts have rated the stock with a sell recommendation, five have given a hold recommendation and five have assigned a buy recommendation to the company. The average 1-year price objective among analysts that have updated their coverage on the stock in the last year is $152.15.

CLX has been the subject of several recent research reports. Citigroup lifted their target price on shares of Clorox from $153.00 to $169.00 and gave the company a “hold” rating in a report on Tuesday, November 20th. Wells Fargo & Co reaffirmed a “hold” rating and set a $157.00 target price on shares of Clorox in a report on Monday, February 4th. Zacks Investment Research raised shares of Clorox from a “sell” rating to a “hold” rating in a report on Monday, January 7th. Morgan Stanley set a $142.00 target price on shares of Clorox and gave the company a “sell” rating in a report on Thursday, December 20th. Finally, Bank of America reaffirmed a “neutral” rating and set a $170.00 target price (up from $150.00) on shares of Clorox in a report on Thursday, December 6th.

CLX opened at $160.14 on Friday. Clorox has a 12-month low of $113.57 and a 12-month high of $167.70. The company has a quick ratio of 0.66, a current ratio of 1.15 and a debt-to-equity ratio of 3.08. The company has a market cap of $20.52 billion, a price-to-earnings ratio of 25.58, a price-to-earnings-growth ratio of 3.95 and a beta of 0.32.

Clorox (NYSE:CLX) last posted its earnings results on Monday, February 4th. The company reported $1.40 earnings per share for the quarter, beating the consensus estimate of $1.32 by $0.08. The firm had revenue of $1.47 billion during the quarter, compared to analyst estimates of $1.47 billion. Clorox had a net margin of 12.65% and a return on equity of 105.97%. The business’s quarterly revenue was up 4.0% on a year-over-year basis. During the same period in the previous year, the firm earned $1.77 EPS. Analysts expect that Clorox will post 6.33 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 10th. Shareholders of record on Wednesday, April 24th will be paid a dividend of $0.96 per share. The ex-dividend date of this dividend is Tuesday, April 23rd. This represents a $3.84 annualized dividend and a yield of 2.40%. Clorox’s dividend payout ratio (DPR) is presently 61.34%.

In other news, SVP Matthew T. Laszlo sold 10,585 shares of the business’s stock in a transaction dated Wednesday, February 6th. The shares were sold at an average price of $153.89, for a total transaction of $1,628,925.65. Following the transaction, the senior vice president now owns 17,994 shares of the company’s stock, valued at approximately $2,769,096.66. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, COO Dawn C. Willoughby sold 25,317 shares of the business’s stock in a transaction dated Monday, December 17th. The shares were sold at an average price of $160.68, for a total transaction of $4,067,935.56. Following the transaction, the chief operating officer now directly owns 28,244 shares in the company, valued at approximately $4,538,245.92. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 41,242 shares of company stock worth $6,532,251. 1.40% of the stock is currently owned by corporate insiders.

Several hedge funds have recently made changes to their positions in the company. Athena Capital Advisors LLC purchased a new stake in Clorox in the 4th quarter valued at about $25,000. Meeder Asset Management Inc. purchased a new stake in Clorox in the 4th quarter valued at about $26,000. Capital Financial Planning LLC purchased a new stake in Clorox in the 4th quarter valued at about $32,000. City Holding Co. raised its holdings in Clorox by 150.0% in the 4th quarter. City Holding Co. now owns 250 shares of the company’s stock valued at $39,000 after buying an additional 150 shares during the period. Finally, G&S Capital LLC raised its holdings in Clorox by 46.4% in the 4th quarter. G&S Capital LLC now owns 262 shares of the company’s stock valued at $40,000 after buying an additional 83 shares during the period. 76.19% of the stock is currently owned by hedge funds and other institutional investors.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

Read More: Understanding Analyst Recommendations

Analyst Recommendations for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.